We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.51%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$28.5B
AUM Growth
+$2.42B
(+9.3%)
Cap. Flow
+$581M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
1,921
New
171
Increased
1,320
Reduced
356
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
VF Corp
VFC
|
+$73.4M |
| 3 |
Amazon
AMZN
|
+$71M |
| 4 |
Stanley Black & Decker
SWK
|
+$60.2M |
| 5 |
Tesla
TSLA
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$158M |
| 2 |
Apple
AAPL
|
+$130M |
| 3 |
Cardinal Health
CAH
|
+$43.7M |
| 4 |
Fortinet
FTNT
|
+$39.6M |
| 5 |
ExxonMobil
XOM
|
+$32.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.73% |
| 2 | Industrials | 12.07% |
| 3 | Consumer Staples | 11.64% |
| 4 | Healthcare | 11.12% |
| 5 | Financials | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLO
1701
DELISTED
Olo Inc
OLO
| $72.3K | ﹤0.01% |
+11,571
| New | +$87.3K |
|
1702
Summit Therapeutics
SMMT
$10.9B
| $70.8K | ﹤0.01% |
16,651
-274
| -2% | -$498 |
|
1703
AvePoint
AVPT
$2.6B
| $69.2K | ﹤0.01% |
16,827
+2,628
| +19% | +$11.2K |
|
1704
Riot Platforms
RIOT
$8.52B
| $69.2K | ﹤0.01% |
20,401
+5,505
| +37% | +$28.4K |
|
1705
W&T Offshore
WTI
$545M
| $67.9K | ﹤0.01% |
12,165
+1,744
| +17% | +$12K |
|
1706
Ginkgo Bioworks
DNA
$481M
| $66.6K | ﹤0.01% |
985
+116
| +13% | +$10.7K |
|
1707
Acco Brands
ACCO
$369M
| $66.2K | ﹤0.01% |
11,839
+1,696
| +17% | +$8.81K |
|
1708
Brookdale Senior Living
BKD
$3.62B
| $65.3K | ﹤0.01% |
23,934
+3,430
| +17% | +$12.8K |
|
1709
Opko Health
OPK
$921M
| $64.9K | ﹤0.01% |
51,950
+7,444
| +17% | +$11.7K |
|
1710
Atara Biotherapeutics
ATRA
$71.2M
| $64.9K | ﹤0.01% |
791
+65
| +9% | +$6.77K |
|
1711
Arbutus Biopharma
ABUS
$865M
| $64.2K | ﹤0.01% |
27,558
+3,043
| +12% | +$7.28K |
|
|
VMEO
1712
DELISTED
Vimeo
VMEO
| $63.2K | ﹤0.01% |
18,422
+2,639
| +17% | +$10.2K |
|
1713
Senseonics Holdings Inc
SENS
$254M
| $62.7K | ﹤0.01% |
3,043
+518
| +21% | +$12K |
|
1714
Lightwave Logic
LWLG
$932M
| $62.7K | ﹤0.01% |
14,537
+2,214
| +18% | +$15.7K |
|
1715
Vaalco Energy
EGY
$594M
| $62.3K | ﹤0.01% |
+13,673
| New | +$68.7K |
|
|
ORGN
1716
DELISTED
Origin Materials
ORGN
| $62.3K | ﹤0.01% |
451
+65
| +17% | +$10.3K |
|
1717
Codexis
CDXS
$135M
| $62.1K | ﹤0.01% |
13,325
+1,068
| +9% | +$5.85K |
|
|
SHCR
1718
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $61.4K | ﹤0.01% |
38,359
+5,904
| +18% | +$10.9K |
|
|
NUTX
1719
Nutex Health
NUTX
$1B
| $61.3K | ﹤0.01% |
+215
| New | +$41.3K |
|
|
NGM
1720
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $60K | ﹤0.01% |
11,961
+823
| +7% | +$5.16K |
|
|
KLRS
1721
Kalaris Therapeutics
KLRS
$88.7M
| $60K | ﹤0.01% |
509
+20
| +4% | +$3.39K |
|
|
BRMK
1722
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $59.7K | ﹤0.01% |
16,756
+2,401
| +17% | +$11.2K |
|
|
NVTA
1723
DELISTED
Invitae Corporation
NVTA
| $58.6K | ﹤0.01% |
31,529
+5,493
| +21% | +$13.4K |
|
|
RDFN
1724
DELISTED
Redfin
RDFN
| $58K | ﹤0.01% |
13,676
+1,959
| +17% | +$9.21K |
|
1725
Karyopharm Therapeutics
KPTI
$168M
| $56.9K | ﹤0.01% |
1,115
+108
| +11% | +$7.49K |
|
Similar funds
ProShare Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, ProShare Advisors held 1,921 positions worth $28.5B, up 9.3% from $26.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ProShare Advisors's Q4 2022 filing shows 171 new, 1,320 increased, 356 reduced and 71 closed positions. Its largest new stake was Rivian: 689,839 shares worth $12.7M. The largest sale was Target, an estimated $158M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q4 2022 buy was Rivian: 689,839 shares worth $12.7M.
- ProShare Advisors added most to Microsoft in Q4 2022, an estimated $111M increase.
- ProShare Advisors's biggest Q4 2022 reduction was Apple, cutting an estimated $130M.
- ProShare Advisors fully exited Target in Q4 2022, selling an estimated $158M.
- ProShare Advisors's ten largest holdings make up 20% of its $28.5B portfolio in Q4 2022.
- ProShare Advisors opened 171 new positions and closed 71 in Q4 2022.
- ProShare Advisors's portfolio value rose 9.3% quarter-over-quarter to $28.5B.
Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.